Literature DB >> 17706194

Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization.

Alex I Chernyavsky1, Juan Arredondo, Douglas E Vetter, Sergei A Grando.   

Abstract

Epithelialization, a major component of wound healing, depends on keratinocyte adhesion and migration. Initiation of migration relies upon the ability of keratinocytes to free themselves from neighboring cells and basement membrane. The local cytotransmitter acetylcholine (ACh) controls keratinocyte adhesion and locomotion through different classes of ACh receptors (AChR). In this study, we explored signaling pathways downstream of the alpha9 AChR subtype that had been shown to control cell shape and cytoplasm mobility. Inactivation of alpha9 signaling by pharmacologic antagonism and RNA interference in keratinocyte cultures and null mutation in knockout mice delayed wound re-epithelialization in vitro and in vivo, respectively, and diminished the extent of colony scattering and cell outgrowth from the megacolony. Although keratinocytes at the leading edge elongated, produced filopodia and moved out, most of them remained anchored to the substrate by long cytoplasmic processes that stretched during their migration instead of retracting the uropod. Since the velocity of keratinocyte migration was not altered, we investigated the role of alpha9 in assembly/disassembly of the cell-cell and cell-matrix adhesion complexes. Stimulation of alpha9 upregulated in a time-dependent fashion phosphorylation of the adhesion molecules comprising focal adhesions (FAK, paxillin) and intercellular junctions (beta-catenin, desmoglein 3) as well as cytokeratins. Stimulation of alpha9 was associated with activation of phospholipase C, Src, EGF receptor kinase, protein kinase C, Rac and Rho, whereas inhibition of this receptor interfered with phosphorylation of adhesion and cytoskeletal proteins, and also altered cell-cell cohesion. We conclude that signaling through alpha9 AChR is critical for completion of the very early stages of epithelialization. By activating alpha9 AChR, ACh can control the dynamics and strength of cell-cell cohesion, disabling of a trailing uropod and disassembly and reassembly of focal adhesions, thus facilitating crawling locomotion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706194      PMCID: PMC2682983          DOI: 10.1016/j.yexcr.2007.07.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  64 in total

1.  Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity.

Authors:  V T Nguyen; A Ndoye; S A Grando
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes.

Authors:  Vu Thuong Nguyen; Alexander I Chernyavsky; Juan Arredondo; Dani Bercovich; Avi Orr-Urtreger; Douglas E Vetter; Jürgen Wess; Arthur L Beaudet; Yasuo Kitajima; Sergei A Grando
Journal:  Exp Cell Res       Date:  2004-04-01       Impact factor: 3.905

3.  The Ras/Raf-1/MEK1/ERK signaling pathway coupled to integrin expression mediates cholinergic regulation of keratinocyte directional migration.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Evert Karlsson; Ignaz Wessler; Sergei A Grando
Journal:  J Biol Chem       Date:  2005-09-08       Impact factor: 5.157

4.  Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor.

Authors:  Paola V Plazas; Eleonora Katz; María E Gomez-Casati; Cecilia Bouzat; A Belén Elgoyhen
Journal:  J Neurosci       Date:  2005-11-23       Impact factor: 6.167

5.  Desmosome assembly and disassembly are regulated by reversible protein phosphorylation in cultured epithelial cells.

Authors:  M Pasdar; Z Li; H Chan
Journal:  Cell Motil Cytoskeleton       Date:  1995

6.  Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive.

Authors:  Larisa Y Romanova; Shigeru Hashimoto; Kee-Oh Chay; Mikhail V Blagosklonny; Hisataka Sabe; J Frederic Mushinski
Journal:  J Cell Sci       Date:  2004-07-13       Impact factor: 5.285

7.  Depletion of total acetylcholine by hemicholinium-3 in isolated rat diaphragm is less in the presence of dexamethasone.

Authors:  R D Veldsema-Currie; W T Labruyère; M W Langemeijer
Journal:  Brain Res       Date:  1984-12-24       Impact factor: 3.252

8.  Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation.

Authors:  S A Grando; A M Crosby; B D Zelickson; M V Dahl
Journal:  J Invest Dermatol       Date:  1993-12       Impact factor: 8.551

9.  Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF).

Authors:  D Cha; P O'Brien; E A O'Toole; D T Woodley; L G Hudson
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

10.  Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior.

Authors:  E E Sander; J P ten Klooster; S van Delft; R A van der Kammen; J G Collard
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  34 in total

1.  Novel cholinergic peptides SLURP-1 and -2 regulate epithelialization of cutaneous and oral wounds.

Authors:  Alexander I Chernyavsky; Mina Kalantari-Dehaghi; Courtney Phillips; Steve Marchenko; Sergei A Grando
Journal:  Wound Repair Regen       Date:  2011-12-13       Impact factor: 3.617

2.  Nicotinic receptor signaling in nonexcitable epithelial cells: paradigm shifting from ion current to kinase cascade. Focus on "Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases".

Authors:  Andrzej Slominski
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-25       Impact factor: 4.249

3.  Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.

Authors:  Layla Azam; J Michael McIntosh
Journal:  J Neurochem       Date:  2012-08-03       Impact factor: 5.372

Review 4.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

5.  Control of lung epithelial growth by a nicotinic acetylcholine receptor: the other side of the coin.

Authors:  Jesse Roman; Michael Koval
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

6.  Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist.

Authors:  Sulan Luo; Dongting Zhangsun; Peta J Harvey; Quentin Kaas; Yong Wu; Xiaopeng Zhu; Yuanyan Hu; Xiaodan Li; Victor I Tsetlin; Sean Christensen; Haylie K Romero; Melissa McIntyre; Cheryl Dowell; James C Baxter; Keith S Elmslie; David J Craik; J Michael McIntosh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 7.  The Roles of Growth Factors in Keratinocyte Migration.

Authors:  Mark A Seeger; Amy S Paller
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

8.  Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor.

Authors:  Jenny C F Wu; Andrzej Chruscinski; Vinicio A De Jesus Perez; Harvir Singh; Maria Pitsiouni; Marlene Rabinovitch; Paul J Utz; John P Cooke
Journal:  J Cell Biochem       Date:  2009-10-01       Impact factor: 4.429

9.  A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Paul Whiteaker; Sean Christensen; Yingxian Xiao; Erin L Meyer; J Michael McIntosh
Journal:  J Neurochem       Date:  2009-07-23       Impact factor: 5.372

Review 10.  Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans.

Authors:  I Wessler; C J Kirkpatrick
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.